Picture of Daito Pharmaceutical Co logo

4577 Daito Pharmaceutical Co Share Price

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedSmall CapSuper Stock

Momentum

Relative Strength (%)
1m-3.02%
3m+2.2%
6m-3.9%
1yr-11.85%
Volume Change (%)
10d/3m-51.36%
Price vs... (%)
52w High-5.64%
50d MA+4.6%
200d MA+15.31%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)15.38
PEG Ratio (f)1.07
EPS Growth (f)16.83%
Dividend Yield (f)3.28%
Valuation (ttm)IndustryMarket
Price to Book Value0.71
Price to Tang. Book0.71
Price to Free Cashflown/a
Price to Sales0.73
EV to EBITDA6.84

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital4.04%
Return on Equity3.67%
Operating Margin4.86%

Financial Summary

Year End 31st MayUnit202120222023202420252026E2027ECAGR / Avg
Total Revenue¥m48,714.9943,46445,10146,89550,64352,70055,2002.39%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+4.19+8.28-27.77-7.48-37.79+16.6+17.34n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st May 202631st May 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of Daito Pharmaceutical Co EPS forecast chart

Profile Summary

Daito Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture, sale, purchase and sale of active pharmaceutical ingredients and formulations (prescription drugs and over-the-counter drugs), contract manufacturing of active pharmaceutical ingredients and formulations, and sale of health foods and other products. The Company is primarily engaged in the pharmaceutical business segment. The main products are active pharmaceutical ingredients and formulations. The Company manufactures, sells, purchases and sells active pharmaceutical ingredients, which are raw materials used to manufacture pharmaceuticals, and undertakes contract manufacturing. The Company also manufactures, sells, purchases and sells formulations of prescription drugs and over-the-counter drugs, and undertakes contract manufacturing.

Directors

Last Annual
May 31st, 2025
Last Interim
May 31st, 2025
Incorporated
June 30th, 1942
Public Since
March 24th, 2010
No. of Shareholders
3,086
No. of Employees
1,073
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
jp flag iconTokyo Stock Exchange
Shares in Issue
29,689,926

4577 Share Price Performance

Upcoming Events for 4577

Similar to 4577

Picture of Astellas Pharma logo

Astellas Pharma

jp flag iconTokyo Stock Exchange

Picture of Astena Holdings Co logo

Astena Holdings Co

jp flag iconTokyo Stock Exchange

Picture of CanBas Co logo

CanBas Co

jp flag iconTokyo Stock Exchange

Picture of CellSeed logo

CellSeed

jp flag iconTokyo Stock Exchange

FAQ